Xml Financial, LLC Abb Vie Inc. Transaction History

Xml Financial, LLC

$1.2 Billion
Q3 2025

A detailed history of Xml Financial, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Xml Financial, LLC holds 10,992 shares of ABBV stock, worth $2.4 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

10,992

Previous 11,209 1.94%

Holding current value

$2.4 Million

Previous $2.08 Million 22.36%

% of portfolio

0.21%

Previous 0.18%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	SELL	$184.85 - $231.54 $40,112 - $50,244	-217 Reduced 1.94%	10,992 $2.55 Million
Q2 2025 Jul 17, 2025	SELL	$170.16 - $206.27 $78,443 - $95,090	-461 Reduced 3.95%	11,209 $2.08 Million
Q1 2025 Apr 22, 2025	SELL	$169.2 - $216.66 $427,737 - $547,716	-2,528 Reduced 17.81%	11,670 $2.45 Million
Q4 2024 Jan 17, 2025	BUY	$164.99 - $203.87 $659 - $815	4 Added 0.03%	14,198 $2.52 Million
Q3 2024 Nov 01, 2024	SELL	$163.84 - $199.33 $27,033 - $32,889	-165 Reduced 1.15%	14,194 $2.8 Million
Q2 2024 Jul 22, 2024	SELL	$154.79 - $180.76 $49,068 - $57,300	-317 Reduced 2.16%	14,359 $2.46 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $353,362 - $402,623	-2,211 Reduced 13.09%	14,676 $2.67 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $28,070 - $31,613	204 Added 1.22%	16,887 $2.62 Million
Q3 2023 Nov 06, 2023	SELL	$133.59 - $154.65 $35,134 - $40,672	-263 Reduced 1.55%	16,683 $2.49 Million
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $36,042 - $44,852	-272 Reduced 1.58%	16,946 $2.28 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $4.83 Million - $5.57 Million	-33,427 Reduced 66.0%	17,218 $2.74 Million
Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $23,374 - $28,032	169 Added 0.33%	50,645 $8.19 Million
Q3 2022 Nov 04, 2022	BUY	$134.21 - $153.93 $5.67 Million - $6.5 Million	42,248 Added 513.47%	50,476 $6.77 Million
Q2 2022 Aug 01, 2022	SELL	$137.62 - $174.96 $5.8 Million - $7.37 Million	-42,109 Reduced 83.65%	8,228 $1.26 Million
Q1 2022 May 02, 2022	SELL	$131.98 - $163.75 $15,573 - $19,322	-118 Reduced 0.23%	50,337 $8.16 Million
Q4 2021 Feb 01, 2022	BUY	$107.43 - $135.93 $1,396 - $1,767	13 Added 0.03%	50,455 $6.83 Million
Q3 2021 Nov 01, 2021	BUY	$106.4 - $120.78 $4.63 Million - $5.25 Million	43,492 Added 625.78%	50,442 $5.44 Million
Q2 2021 Aug 10, 2021	SELL	$105.21 - $117.21 $4,944 - $5,508	-47 Reduced 0.67%	6,950 $783,000
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $92,479 - $101,808	-904 Reduced 11.44%	6,997 $757,000
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $89,987 - $121,493	1,118 Added 16.48%	7,901 $847,000
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $162,541 - $190,770	1,892 Added 38.68%	6,783 $594,000
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $63,538 - $85,023	866 Added 21.52%	4,891 $480,000
Q1 2020 May 08, 2020	SELL	$64.5 - $97.79 $44,698 - $67,768	-693 Reduced 14.69%	4,025 $307,000
Q4 2019 Feb 04, 2020	BUY	$72.13 - $90.25 $340,309 - $425,799	4,718 New	4,718 $418,000

Others Institutions Holding ABBV

# of Institutions

4,382

Shares Held

1.3B

Call Options Held

16.1M

Put Options Held

10.9M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $386B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xml Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xml Financial, LLC with notifications on news.

Account

Xml Financial, LLC Abb Vie Inc. Transaction History